Axcelis Technologies Inc
NASDAQ:ACLS

Watchlist Manager
Axcelis Technologies Inc Logo
Axcelis Technologies Inc
NASDAQ:ACLS
Watchlist
Price: 90.07 USD 1.26% Market Closed
Market Cap: 2.8B USD

Axcelis Technologies Inc
Investor Relations

Axcelis Technologies Inc., a dynamic player in the semiconductor equipment industry, has carved its niche with a focus on ion implantation systems, an essential component in the fabrication of semiconductor chips. Picture a bustling factory floor, where intricate machines whir with precision; this is the heart of Axcelis's operations. The company designs and manufactures these high-tech systems that are crucial in controlling the electrical characteristics of silicon wafers. Through a process involving the acceleration and embedding of ions into the silicon lattice, Axcelis's technology plays a critical role in determining the speed, power consumption, and efficiency of electronic devices. This specialization has allowed the company to establish itself as a backbone in the semiconductor supply chain, supporting industries from consumer electronics to automotive manufacturing.

Revenue for Axcelis is primarily derived from the sale of these ion implantation systems and the accompanying extensive aftermarket services. Imagine a meticulous caretaker, ensuring that each machine it has placed in the vast network of global factories runs seamlessly. The company not only provides initial installations but also offers maintenance, spare parts, and system upgrades—integral components that ensure the prolonged lifecycle and enhanced performance of its equipment. As the semiconductor industry continues to experience rapid evolution, driven by the increasing demand for more powerful and efficient chips, Axcelis finds itself in a favorable position. By continually investing in research and development, the company aims to adapt its technology to the ever-changing needs of chip manufacturers, securing its place in the competitive landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 4, 2025
AI Summary
Q3 2025

Revenue Beat: Axcelis reported Q3 revenue of $214 million, exceeding its outlook.

Profitability: Non-GAAP diluted EPS was $1.21, above the expected $1.00, driven by higher revenue and lower operating expenses.

CS&I Growth: Aftermarket (CS&I) revenue hit a record $70 million, up 9% year-over-year for the first nine months.

Bookings Down: Q3 bookings declined sequentially, mainly due to softer power and general mature segments, but are expected to improve in Q4.

Merger Update: Management highlighted the pending merger with Veeco, emphasizing cross-sell and technology synergies and a stronger market position.

China Exposure: Sales to China fell to 46% of total revenue, down from 55% in Q2, and are anticipated to decline again in Q4.

Q4 Guidance: Revenue expected at $215 million, with gross margin rebounding to 43% and non-GAAP EPS around $1.12.

Sector Trends: Management sees memory as a bright spot for 2026, while silicon carbide demand remains healthy but will fluctuate.

Key Financials
Revenue
$214 million
CS&I Revenue
$70 million
Bookings
$52 million
Backlog
$484 million
Gross Margin
41.6%
Operating Expenses
$63.8 million
Operating Margin
11.7%
Adjusted EBITDA
$43 million
Adjusted EBITDA Margin
20.2%
Tax Rate
14%
Diluted Shares Outstanding
31.5 million
EPS (Diluted)
$0.83
EPS (Diluted, Non-GAAP)
$1.21
Free Cash Flow
$43 million
Cash, Cash Equivalents and Marketable Securities
$593 million
Share Repurchases
$32 million in Q3; $135 million remaining under program
Earnings Call Recording
Other Earnings Calls

Management

Dr. Russell J. Low Ph.D.
CEO, President & Director
No Bio Available
Mr. James G. Coogan
Executive VP & CFO
No Bio Available
Ms. Lynnette C. Fallon J.D.
Executive VP of Human Resources & Legal, General Counsel and Corporate Secretary
No Bio Available
Mr. Gregory F. Redinbo Ph.D.
Executive Vice President of Marketing & Applications
No Bio Available
Mr. Gerald M. Blumenstock
Executive Vice President of Engineering
No Bio Available
Mr. Robert Mahoney
Senior Vice President of Global Operations
No Bio Available
Mr. David Ryzhik
Senior Vice President of Investor Relations and Corporate Strategy
No Bio Available
Mr. Douglas A. Lawson
Senior Advisor
No Bio Available
Dr. Christopher Tatnall Ph.D.
Executive Vice President of Global Customer Operations
No Bio Available

Contacts

Address
MASSACHUSETTS
Beverly
108 Cherry Hill Dr
Contacts
+19787874000.0
www.axcelis.com